✦ LIBER ✦
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer
✍ Scribed by Masanori Noguchi; Tatsuyuki Kakuma; Hirotsugu Uemura; Yasutomo Nasu; Hiromi Kumon; Yasuhiko Hirao; Fukuko Moriya; Shigetaka Suekane; Kei Matsuoka; Nobukazu Komatsu; Shigeki Shichijo; Akira Yamada; Kyogo Itoh
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 422 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.